IDYA position history
The shares of Ideaya Biosciences (IDYA) that DAFNA Capital Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 460,061 shares, $12M, 3.1% of portfolio
- 2021 Q4: 460,061 shares, $11M, 2.7% of portfolio
- 2022 Q1: 490,061 shares, $5.5M, 1.4% of portfolio, Add +6.5%
- 2022 Q2: 548,561 shares, $7.6M, 2.1% of portfolio, Add +11.9%
- 2022 Q3: 538,561 shares, $8M, 2.2% of portfolio, Reduce −1.8%
- 2022 Q4: 468,358 shares, $8.5M, 2.4% of portfolio, Reduce −13.0%
- 2023 Q1: 468,358 shares, $6.4M, 1.9% of portfolio
- 2023 Q2: 479,820 shares, $11M, 3.1% of portfolio, Add +2.4%
- 2023 Q3: 499,820 shares, $13M, 4.2% of portfolio, Add +4.2%
- 2023 Q4: 516,341 shares, $18M, 4.4% of portfolio, Add +3.3%
- 2024 Q1: 446,341 shares, $20M, 4.5% of portfolio, Reduce −13.6%
- 2024 Q2: 422,213 shares, $15M, 3.5% of portfolio, Reduce −5.4%
- 2024 Q3: 471,410 shares, $15M, 3.5% of portfolio, Add +11.7%
- 2024 Q4: 498,827 shares, $13M, 3.3% of portfolio, Add +5.8%
- 2025 Q1: 589,330 shares, $9.7M, 2.7% of portfolio, Add +18.1%
- 2025 Q2: 619,090 shares, $13M, 3.6% of portfolio, Add +5.0%
- 2025 Q3: 539,923 shares, $15M, 3.6% of portfolio, Reduce −12.8%
- 2025 Q4: 506,740 shares, $18M, 4.1% of portfolio, Reduce −6.1%
- 2026 Q1: 476,740 shares, $16M, 3.6% of portfolio, Reduce −5.9%
- 2026 Q2: 497,240 shares, $19M, 3.5% of portfolio, Add +4.3%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|